FDA Moves to Ban Gas Station and Kratom Products with Opioid-Like Effects

TL;DR Summary
The FDA is recommending regulatory action to control 7-hydroxymitragynine (7-OH), a potent opioid byproduct of the kratom plant, due to its abuse potential and presence in unregulated products, especially those appealing to youth. The agency emphasizes the risks and is working to prevent a new wave of opioid addiction by alerting healthcare professionals and consumers, and collaborating with the DEA for scheduling.
- FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers fda.gov
- FDA asks Justice Department to classify gas station products with opioid-like effects as illicit substances NBC News
- Products with opioid-like effects sold at gas stations may be banned as illicit substances USA Today
- US health officials crack down on kratom-related products after complaints from supplement industry AP News
- FDA pushes for federal oversight of potent kratom compound Axios
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 3 min read
Condensed
89%
560 → 62 words
Want the full story? Read the original article
Read on fda.gov